Nikole T Schilling, OD | |
2101 Burlington Beach Rd., Valparaiso, IN 46383-0000 | |
(219) 462-0309 | |
(219) 464-4291 |
Full Name | Nikole T Schilling |
---|---|
Gender | Female |
Speciality | Optometry |
Experience | 21 Years |
Location | 2101 Burlington Beach Rd., Valparaiso, Indiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154398097 | NPI | - | NPPES |
200530340B | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 18003239A (Indiana) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Northwest Indiana Eye Associates Pc | 1355319583 | 8 |
News Archive
Lead is a toxic heavy metal that was added to petrol for use in cars until as recently as 25 years ago. It is particularly harmful to the developing brains of infants, children and teenagers, and the damage it does is irreversible.
The Skipton Fund, the body set up to administer the UK-wide ex gratia payment scheme for people infected with Hepatitis C from NHS blood or blood products, will launch and begin processing applications on July 5 2004.
An international group of public and private organizations is collaborating to accelerate development of an innovative heat-stable and low-cost inhaled form of oxytocin to manage postpartum hemorrhage in resource-poor settings.
Robert McDonald promised to fix problems at the Department of Veterans Affairs that kept veterans from getting care.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the first patients have been dosed in a Phase 3 clinical study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, in adults with moderate-to-severe atopic dermatitis (AD) that is not adequately controlled with topical AD medications.
› Verified 6 days ago
Provider Name | Northwest Indiana Eye Associates Pc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1336115237 PECOS PAC ID: 1355319583 Enrollment ID: O20040924000081 |
News Archive
Lead is a toxic heavy metal that was added to petrol for use in cars until as recently as 25 years ago. It is particularly harmful to the developing brains of infants, children and teenagers, and the damage it does is irreversible.
The Skipton Fund, the body set up to administer the UK-wide ex gratia payment scheme for people infected with Hepatitis C from NHS blood or blood products, will launch and begin processing applications on July 5 2004.
An international group of public and private organizations is collaborating to accelerate development of an innovative heat-stable and low-cost inhaled form of oxytocin to manage postpartum hemorrhage in resource-poor settings.
Robert McDonald promised to fix problems at the Department of Veterans Affairs that kept veterans from getting care.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the first patients have been dosed in a Phase 3 clinical study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, in adults with moderate-to-severe atopic dermatitis (AD) that is not adequately controlled with topical AD medications.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Nikole T Schilling, OD 2101 Burlington Beach Rd., Valparaiso, IN 46383-0000 Ph: (219) 462-0309 | Nikole T Schilling, OD 2101 Burlington Beach Rd., Valparaiso, IN 46383-0000 Ph: (219) 462-0309 |
News Archive
Lead is a toxic heavy metal that was added to petrol for use in cars until as recently as 25 years ago. It is particularly harmful to the developing brains of infants, children and teenagers, and the damage it does is irreversible.
The Skipton Fund, the body set up to administer the UK-wide ex gratia payment scheme for people infected with Hepatitis C from NHS blood or blood products, will launch and begin processing applications on July 5 2004.
An international group of public and private organizations is collaborating to accelerate development of an innovative heat-stable and low-cost inhaled form of oxytocin to manage postpartum hemorrhage in resource-poor settings.
Robert McDonald promised to fix problems at the Department of Veterans Affairs that kept veterans from getting care.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the first patients have been dosed in a Phase 3 clinical study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, in adults with moderate-to-severe atopic dermatitis (AD) that is not adequately controlled with topical AD medications.
› Verified 6 days ago
Dr. Richard Scott Carlson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 502 Marquette St, Valparaiso, IN 46383 Phone: 219-464-8223 Fax: 219-531-2356 | |
Stephen R Buck, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 502 Marquette St, Valparaiso, IN 46383 Phone: 219-464-8223 Fax: 219-531-2356 | |
Stanley N. Blackman, O.d., P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2009 Roosevelt Rd, Suite D, Valparaiso, IN 46383 Phone: 219-462-5501 Fax: 219-462-3238 | |
Dr. Phillip George Koultourides, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2400 Morthland Dr, Valparaiso, IN 46383 Phone: 219-465-2788 Fax: 219-465-2785 | |
D/b/a Lewyckyj-taglia- Felton Eye Clinics Optometrist Medicare: Medicare Enrolled Practice Location: 2101 Burlington Beach Rd, Valparaiso, IN 46383 Phone: 219-462-0309 Fax: 219-464-4291 | |
Northwest Indiana Eye & Laser Center Pc Optometrist Medicare: Medicare Enrolled Practice Location: 502 Marquette St, Valparaiso, IN 46383 Phone: 219-464-8223 Fax: 219-531-2356 |